ePOSTER WALLView allEpidemiology of MSImmunology of MSMRI in MSMS DiagnosisMS PathologyNeuromyelitis OpticaPediatric MSRecent Advances in MS Therapy Clinical, Evolutionary and Etiological Particularities of Inflammatory Optic Neuropathies: An Algerian Population View ePoster Real-World Experience with Cladribine in the MSBase Registry View ePoster Anti-Inflammatory Compounds Ameliorate Locomotion and Anxiety Behaviors in Cuprizone Mouse Model of Multiple Sclerosis View ePoster Neurofilament Light Chains: A Reliable Biomarker of Disease Activity in MS View ePoster The Relationship Between Smoking and Multiple Sclerosis Severity in Saudi Arabia View ePoster Phenotyping the Pediatric Demyelinating Events at the Multiple Sclerosis Center at the American University of Beirut View ePoster Lennox-Gastaut Syndrome and MS: Is it a Coincidence? View ePoster NMOSD: How Long to Treat View ePoster The Psychological Effect of COVID19 Pandemic on Neuromyelitis Optica Spectrum Disorder Patients and Their Attitude Change After a Year of the Pandemic in Isfahan, Iran. View ePoster A Child with Intractable Vomiting: Brainstem Mass or Neuromyelitis Optica Spectrum Disorder View ePoster Clinical Characteristics of Switching Between Disease Modifying Drugs Among a Sample of Egyptian Multiple Sclerosis Patients View ePoster Cognitive Impairment in Neuromyelitis Optica Spectrum Disorder and Brain Parenchyma Volume by Transcranial Sonography View ePoster Association of Multiple Sclerosis and COVID-19 Infection: A Case Report View ePoster Does Multiple Sclerosis Change Lower Limbs Inter-Segmental Coordination During Walking? View ePoster Cognitive Dual Tasking Impacts Lower Limbs Inter-Segmental Coordination During Walking in Patients with Multiple Sclerosis View ePoster Effects of Cognitive and Motor Secondary Tasks on Gait Performance in Healthy Controls and Multiple Sclerosis Patients with and Without Fall History View ePoster Sleep Disorders in Multiple Sclerosis Patients View ePoster Anxiety in Patients with Multiple Sclerosis View ePoster Depression in Multiple Sclerosis View ePoster Claims-Based Relapse and Hospitalization Rates in Patients with Multiple Sclerosis Treated with Natalizumab or Ocrelizumab View ePoster Real-world experience on the use of COVID-19 vaccination in patients with multiple sclerosis treated with Cladribine tablets in the Gulf region View ePoster Real-world experience on the use of COVID-19 vaccination in patients with multiple sclerosis treated with Cladribine tablets in the Gulf region View ePoster Patient Reported Outcomes of New Brand-Generic Product of Teriflunomide in Patients with Relapsing-Remitting Multiple Sclerosis: Preliminary Analysis View ePoster Long-Term Efficacy for Patients Receiving Cladribine Tablets in CLARITY/CLARITY Extension: Primary Results from 9–15 Years of Follow-Up in the CLASSIC-MS Study View ePoster Pregnancy Outcomes in Patients with Multiple Sclerosis Following Exposure to Ofatumumab View ePoster Epidemiology of COVID-19 in Patients with MS: A Hospital-Based Registry View ePoster Variables Affecting Disease Modifying Therapy Adherence and Impact of Adherence on Multiple Sclerosis Patients (Egyptian Experience) View ePoster The Effect of Rituximab on Mood Disorders in Multiple Sclerosis View ePoster Serum Neurofilament Light Chain as a Biomarker in Multiple Sclerosis View ePoster Treatment of Progressive Multifocal Leukoencephalopathy with Pembrolizumab View ePoster Economic Analysis for Introduction of Cladribine Tablets as a Treatment for Relapsing Multiple Sclerosis Patients with High Disease Activity in Kuwait View ePoster Primary Results of NOVA: A Randomized Controlled Study of the Efficacy of 6 Week Dosing of Natalizumab Versus Continued 4-Week Treatment for Multiple Sclerosis View ePoster Comparison of Time to Clinically Meaningful Improvement in Neuro-QOL in Patients Treated with Natalizumab Versus Ocrelizumab View ePoster Vitamin D3 Improves Behavioral Dysfunction and Promotes Remyelination in Multiple Sclerosis Model Induced by Cuprizone View ePoster Improvements in Quality of Life at 1 Year in Patients Treated with Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis: An Interim Analysis of Clarify-MS View ePoster Multiple Sclerosis Specialized Nurses in Saudi Arabia: Challenge, and Opportunities View ePoster Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets View ePoster Prevalence of Urinary Tract Symptoms in Patients with Multiple Sclerosis and Health Care Seeking Behavior: A Cross Sectional Study in Riyadh, Saudi Arabia. View ePoster Epidemiology of Multiple Sclerosis in Iraq: Retrospective Review of 4355 Cases and Literature Review View ePoster Multiple Sclerosis During Pregnancy: Data from the MS Clinic in Benghazi Medical Center View ePoster COVID-19 Vaccination in People with Multiple Sclerosis. the Kuwait Experience View ePoster Incidence, Severity, Outcomes, and Risk Factors of COVID-19 in Multiple Sclerosis: An Observational Study in the Middle East View ePoster Challenges of MS Patients for Receiving Health Care Services View ePoster Familial MS in the South Caspian Sea View ePoster Gender Based Epidemiologic Survey of Multiple Sclerosis Patients, a Report from Isfahan Province, Iran. View ePoster A Nationwide Pharmaco Epidemiological Study of Multiple Sclerosis in Greece View ePoster Water-Pipe and Cigarette Smoking, Drug Abuse and Alcohol Consumption and the Risk of Primary Progressive Multiple Sclerosis: A Population Based Case-Control Study View ePoster Medication Adherence Among Patients with Multiple Sclerosis During the COVID-19 Pandemic: Perspective from the Near East Region View ePoster Inform Interferon Beta Exposure in the 2nd and 3rd Trimester of Pregnancy: A Register-Based Drug Utilisation Study in Finland and Sweden View ePoster Sociodemographic Characteristics of Patients with Multiple Sclerosis Disease in Morocco. View ePoster Telemedicine and Multiple Sclerosis Management in the Era of COVID-19, Al-Azhar Experience View ePoster Initial Clinical and Neuroradiological Features at Presentation of Patients with Multiple Sclerosis: A Hospital-Based Experience from Oman View ePoster Demographic and Clinical Characteristics of Patients with Benign MS in Compare with Non-Benign MS View ePoster Impact of Gender on Multiple Sclerosis Natural History: Findings from a Tunisian Cohort View ePoster The Effect of Seasonal Variation on Relapse Rate in Patients with Relapsing-Remitting Multiple Sclerosis in Saudi Arabia View ePoster The Role of Gut Microbiata in Multiple Sclerosis View ePoster Radiologically Isolated Syndrome Conversion to Multiple Sclerosis View ePoster A Challenging Case of Central Nervous System (CNS) Involvement with Chronic Lymphocytic Leukaemia (CLL): A Case Report View ePoster Psychotic Symptoms Revealing Multiple Sclerosis: Case Report View ePoster Analysis of Visual Acuity, Contrast Sensitivity and Color Perception in Multiple Sclerosis Patients View ePoster Depression, Anxiety and Alexithymia in Tunisian Patients with Multiple Sclerosis View ePoster Adrenoleukodystrophy in Adults: About a Case View ePoster MRI Findings in Late-Onset Multiple Sclerosis; a Systematic Review and Meta-Analysis View ePoster Chitinase-3 Like-Protein-1 in CSF: A Novel Biomarker for Progression in Multiple Sclerosis Patients View ePoster Demographic and Clinical Characteristics of Progressive Multiple Sclerosis: Findings from a Tunisian Cohort Study View ePoster COVID-19 in Multiple Sclerosis Patients in Dubai: Observational Study View ePoster Humoral Immune Response to SARS-CoV-2 Vaccination in MS Patients View ePoster Association of COVID-19 with Disability Progression and Disease Exacerbation in People with Relapsing-Remitting Multiple Sclerosis: Evidence from a Year-Long Observational Study View ePoster MicroRNA-484 and Apoptotic Protease Activating Factor-1 Gene in Relapsing Remitting Multiple Sclerosis: the Possible Interplay View ePoster The Effect of Disease Modifying Drugs of Multiple Sclerosis on the Effectiveness of BBIBP-CorV COVID-19 Vaccine View ePoster First Study in Iraq About (HLA)-Drb1 * 15:01 as a Genetic Risk Factor for MS Initiation View ePoster Evaluation of Anti-JVC Antibody Index Evolution in Patients with Multiple Sclerosis View ePoster Prevalence of MS in Tehran, Iran in 2020 and Its Forecast for the Next 10 Years View ePoster
Clinical, Evolutionary and Etiological Particularities of Inflammatory Optic Neuropathies: An Algerian Population View ePoster
Anti-Inflammatory Compounds Ameliorate Locomotion and Anxiety Behaviors in Cuprizone Mouse Model of Multiple Sclerosis View ePoster
Phenotyping the Pediatric Demyelinating Events at the Multiple Sclerosis Center at the American University of Beirut View ePoster
The Psychological Effect of COVID19 Pandemic on Neuromyelitis Optica Spectrum Disorder Patients and Their Attitude Change After a Year of the Pandemic in Isfahan, Iran. View ePoster
A Child with Intractable Vomiting: Brainstem Mass or Neuromyelitis Optica Spectrum Disorder View ePoster
Clinical Characteristics of Switching Between Disease Modifying Drugs Among a Sample of Egyptian Multiple Sclerosis Patients View ePoster
Cognitive Impairment in Neuromyelitis Optica Spectrum Disorder and Brain Parenchyma Volume by Transcranial Sonography View ePoster
Cognitive Dual Tasking Impacts Lower Limbs Inter-Segmental Coordination During Walking in Patients with Multiple Sclerosis View ePoster
Effects of Cognitive and Motor Secondary Tasks on Gait Performance in Healthy Controls and Multiple Sclerosis Patients with and Without Fall History View ePoster
Claims-Based Relapse and Hospitalization Rates in Patients with Multiple Sclerosis Treated with Natalizumab or Ocrelizumab View ePoster
Real-world experience on the use of COVID-19 vaccination in patients with multiple sclerosis treated with Cladribine tablets in the Gulf region View ePoster
Real-world experience on the use of COVID-19 vaccination in patients with multiple sclerosis treated with Cladribine tablets in the Gulf region View ePoster
Patient Reported Outcomes of New Brand-Generic Product of Teriflunomide in Patients with Relapsing-Remitting Multiple Sclerosis: Preliminary Analysis View ePoster
Long-Term Efficacy for Patients Receiving Cladribine Tablets in CLARITY/CLARITY Extension: Primary Results from 9–15 Years of Follow-Up in the CLASSIC-MS Study View ePoster
Variables Affecting Disease Modifying Therapy Adherence and Impact of Adherence on Multiple Sclerosis Patients (Egyptian Experience) View ePoster
Economic Analysis for Introduction of Cladribine Tablets as a Treatment for Relapsing Multiple Sclerosis Patients with High Disease Activity in Kuwait View ePoster
Primary Results of NOVA: A Randomized Controlled Study of the Efficacy of 6 Week Dosing of Natalizumab Versus Continued 4-Week Treatment for Multiple Sclerosis View ePoster
Comparison of Time to Clinically Meaningful Improvement in Neuro-QOL in Patients Treated with Natalizumab Versus Ocrelizumab View ePoster
Vitamin D3 Improves Behavioral Dysfunction and Promotes Remyelination in Multiple Sclerosis Model Induced by Cuprizone View ePoster
Improvements in Quality of Life at 1 Year in Patients Treated with Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis: An Interim Analysis of Clarify-MS View ePoster
Prevalence of Urinary Tract Symptoms in Patients with Multiple Sclerosis and Health Care Seeking Behavior: A Cross Sectional Study in Riyadh, Saudi Arabia. View ePoster
Epidemiology of Multiple Sclerosis in Iraq: Retrospective Review of 4355 Cases and Literature Review View ePoster
Incidence, Severity, Outcomes, and Risk Factors of COVID-19 in Multiple Sclerosis: An Observational Study in the Middle East View ePoster
Gender Based Epidemiologic Survey of Multiple Sclerosis Patients, a Report from Isfahan Province, Iran. View ePoster
Water-Pipe and Cigarette Smoking, Drug Abuse and Alcohol Consumption and the Risk of Primary Progressive Multiple Sclerosis: A Population Based Case-Control Study View ePoster
Medication Adherence Among Patients with Multiple Sclerosis During the COVID-19 Pandemic: Perspective from the Near East Region View ePoster
Inform Interferon Beta Exposure in the 2nd and 3rd Trimester of Pregnancy: A Register-Based Drug Utilisation Study in Finland and Sweden View ePoster
Sociodemographic Characteristics of Patients with Multiple Sclerosis Disease in Morocco. View ePoster
Telemedicine and Multiple Sclerosis Management in the Era of COVID-19, Al-Azhar Experience View ePoster
Initial Clinical and Neuroradiological Features at Presentation of Patients with Multiple Sclerosis: A Hospital-Based Experience from Oman View ePoster
Demographic and Clinical Characteristics of Patients with Benign MS in Compare with Non-Benign MS View ePoster
The Effect of Seasonal Variation on Relapse Rate in Patients with Relapsing-Remitting Multiple Sclerosis in Saudi Arabia View ePoster
A Challenging Case of Central Nervous System (CNS) Involvement with Chronic Lymphocytic Leukaemia (CLL): A Case Report View ePoster
Analysis of Visual Acuity, Contrast Sensitivity and Color Perception in Multiple Sclerosis Patients View ePoster
Chitinase-3 Like-Protein-1 in CSF: A Novel Biomarker for Progression in Multiple Sclerosis Patients View ePoster
Demographic and Clinical Characteristics of Progressive Multiple Sclerosis: Findings from a Tunisian Cohort Study View ePoster
Association of COVID-19 with Disability Progression and Disease Exacerbation in People with Relapsing-Remitting Multiple Sclerosis: Evidence from a Year-Long Observational Study View ePoster
MicroRNA-484 and Apoptotic Protease Activating Factor-1 Gene in Relapsing Remitting Multiple Sclerosis: the Possible Interplay View ePoster
The Effect of Disease Modifying Drugs of Multiple Sclerosis on the Effectiveness of BBIBP-CorV COVID-19 Vaccine View ePoster
